Search
for

    Research

    5 / 451 results

    Community Join

    1 / 1000+ results

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  122 upvotes 9 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.